Exelixis (EXEL) Interest & Investment Income (2017 - 2026)
Exelixis (EXEL) recorded Interest & Investment Income of $14.21 million in Q2 2027, down 15.4% from $16.79 million a year earlier and down 11.9% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Interest & Investment Income (2017 - 2026) Analysis & Trends
On a TTM basis, Exelixis' Interest & Investment Income came in at $63.69 million as of Jul 3, 2026, down 16.1% year-over-year; for FY2026, it came in at $69.21 million, down 10.3% from FY2025.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 55.3% (FY2021 to FY2026).
- Across earlier years, Interest & Investment Income came in at $77.16 million in FY2025, $86.54 million in FY2023 (+161.7%) and $33.07 million in FY2022 (+331.0%).
- The Q2 2027 figure is the lowest quarterly Interest & Investment Income since Q3 2021.
- On a year-over-year basis, Interest & Investment Income has declined for six consecutive quarters, with an average decline of 11.8% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $16.13 million (Q1 2027), $17.43 million (Q4 2026) and $15.92 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Exelixis | 14.53 Bn | 10.87 Bn | 608.03 Mn | 14.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 14.21 Mn |
| Apr 3, 2026 | 16.13 Mn |
| Jan 2, 2026 | 17.43 Mn |
| Oct 3, 2025 | 15.92 Mn |
| Jul 4, 2025 | 16.79 Mn |
| Apr 4, 2025 | 19.08 Mn |
| Jan 3, 2025 | 21.30 Mn |
| Sep 27, 2024 | 18.71 Mn |
| Jun 28, 2024 | 17.26 Mn |
| Mar 29, 2024 | 19.89 Mn |
| Dec 29, 2023 | 21.39 Mn |
| Sep 29, 2023 | 23.11 Mn |
| Jun 30, 2023 | 22.54 Mn |
| Mar 31, 2023 | 19.50 Mn |
| Dec 30, 2022 | 16.99 Mn |
| Sep 30, 2022 | 9.50 Mn |
| Jul 1, 2022 | 4.76 Mn |
| Apr 1, 2022 | 1.82 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Oct 1, 2021 | 1.66 Mn |
API Access
Exelixis Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();